Conclusion: The bulk drug quality and production technology may lead to quality differences of lamivudinetablets.
结论:原料药质量和产品处方工艺不同是导致不同厂家生产拉米夫定片剂质量差异的关键因素。
2
Result: There were significant differences in dissolution procession as well as impurities between two lamivudinetablets.
结果:两家产品溶出行为有显著差异,有关物质量也有明显区别。
3
Objective To study the effect of compound fetal bovine liver extract tablets in combination with lamivudine on hepatic fibrosis in patients with chronic hepatitis B.